Gastroretentive Drug Delivery Systems: Technological Advances, Polymeric Strategies, and Clinical Applications for Enhanced Oral Bioavailability
International Journal of Drug Delivery Technology · 25.05.2026 · 16 (39s)
DOI: 10.25258/ijddt.16.39s.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, erschienen am 25.05.2026. Verfasst von Yogesh . und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Gastroretentive drug delivery systems (GRDDS) represent a significant advancement in oral pharmaceutical technology, designed to prolong gastric residence time and optimize drug absorption from the upper gastrointestinal tract. This comprehensive review examines the physiological basis, technological approaches, polymeric strategies, and clinical applications of gastroretentive systems. The fundamental challenge in oral drug delivery—rapid gastric emptying and variable transit time—is addressed through various retention mechanisms including floating systems (effervescent and non-effervescent), bioadhesive systems, high-density systems, expandable systems, and magnetic systems. Floating drug delivery systems utilize buoyancy principles with gas-generating agents and hydrophilic polymers such as hydroxypropyl methylcellulose (HPMC) and polyethylene oxide to achieve prolonged gastric retention exceeding 12 hours. Non-floating approaches employ mucoadhesion, swelling, or density manipulation to enhance retention. Critical formulation parameters including polymer selection, matrix composition, and excipient functionality are discussed alongside comprehensive evaluation methodologies encompassing buoyancy studies, dissolution testing, and in vivo assessment techniques. The review highlights ideal drug candidates benefiting from gastroretention—particularly those with narrow absorption windows, acid stability, and local gastric action—with metoprolol succinate presented as a clinically relevant case study. Patent landscape and commercial developments demonstrate growing pharmaceutical interest. Current limitations and future perspectives including personalized medicine approaches and emerging technologies are critically analyzed. Gastroretentive systems offer substantial therapeutic advantages through enhanced bioavailability, reduced dosing frequency, minimized side effects, and improved patient compliance, positioning them as promising platforms for next-generation oral drug delivery.
Zitieren
APA
., Y., C, K., R, R., R, M., & K, J. (2026). Gastroretentive Drug Delivery Systems: Technological Advances, Polymeric Strategies, and Clinical Applications for Enhanced Oral Bioavailability. International Journal of Drug Delivery Technology, 16(39s). https://doi.org/10.25258/ijddt.16.39s.11
Vancouver
. Y, C K, R R, R M, K J. Gastroretentive Drug Delivery Systems: Technological Advances, Polymeric Strategies, and Clinical Applications for Enhanced Oral Bioavailability. International Journal of Drug Delivery Technology. 2026;16(39s). doi:10.25258/ijddt.16.39s.11
BibTeX
@article{2026,
author = {., Yogesh and C, Kumar and R, Redhu and R, Mehra and K, Jangra},
title = {Gastroretentive Drug Delivery Systems: Technological Advances, Polymeric Strategies, and Clinical Applications for Enhanced Oral Bioavailability},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {39s},
doi = {10.25258/ijddt.16.39s.11}
}
EUVIMED